nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—prostate gland—urinary bladder cancer	0.0713	0.223	CbGeAlD
Mupirocin—IARS—epithelium—urinary bladder cancer	0.0524	0.164	CbGeAlD
Mupirocin—IARS—smooth muscle tissue—urinary bladder cancer	0.0505	0.158	CbGeAlD
Mupirocin—IARS—renal system—urinary bladder cancer	0.0486	0.152	CbGeAlD
Mupirocin—IARS—female reproductive system—urinary bladder cancer	0.0389	0.122	CbGeAlD
Mupirocin—IARS—vagina—urinary bladder cancer	0.0352	0.11	CbGeAlD
Mupirocin—Application site burn—Fluorouracil—urinary bladder cancer	0.0326	0.048	CcSEcCtD
Mupirocin—IARS—lymph node—urinary bladder cancer	0.0228	0.0712	CbGeAlD
Mupirocin—Stinging—Mitomycin—urinary bladder cancer	0.0203	0.0298	CcSEcCtD
Mupirocin—Application site pain—Fluorouracil—urinary bladder cancer	0.0156	0.0229	CcSEcCtD
Mupirocin—Blepharitis—Fluorouracil—urinary bladder cancer	0.0111	0.0163	CcSEcCtD
Mupirocin—Sensitisation—Epirubicin—urinary bladder cancer	0.00932	0.0137	CcSEcCtD
Mupirocin—Sensitisation—Doxorubicin—urinary bladder cancer	0.00863	0.0127	CcSEcCtD
Mupirocin—Stinging—Fluorouracil—urinary bladder cancer	0.00844	0.0124	CcSEcCtD
Mupirocin—Furunculosis—Methotrexate—urinary bladder cancer	0.00837	0.0123	CcSEcCtD
Mupirocin—Dermatitis contact—Thiotepa—urinary bladder cancer	0.00817	0.012	CcSEcCtD
Mupirocin—Tenderness—Gemcitabine—urinary bladder cancer	0.00797	0.0117	CcSEcCtD
Mupirocin—Tenderness—Fluorouracil—urinary bladder cancer	0.00784	0.0115	CcSEcCtD
Mupirocin—Furunculosis—Epirubicin—urinary bladder cancer	0.00783	0.0115	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Methotrexate—urinary bladder cancer	0.00771	0.0113	CcSEcCtD
Mupirocin—Cellulitis—Gemcitabine—urinary bladder cancer	0.00765	0.0112	CcSEcCtD
Mupirocin—Cellulitis—Fluorouracil—urinary bladder cancer	0.00752	0.0111	CcSEcCtD
Mupirocin—Tenderness—Cisplatin—urinary bladder cancer	0.00743	0.0109	CcSEcCtD
Mupirocin—Furuncle—Methotrexate—urinary bladder cancer	0.00725	0.0107	CcSEcCtD
Mupirocin—Furunculosis—Doxorubicin—urinary bladder cancer	0.00725	0.0107	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Epirubicin—urinary bladder cancer	0.00721	0.0106	CcSEcCtD
Mupirocin—Erythema—Mitomycin—urinary bladder cancer	0.00719	0.0106	CcSEcCtD
Mupirocin—Cellulitis—Cisplatin—urinary bladder cancer	0.00713	0.0105	CcSEcCtD
Mupirocin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00696	0.0102	CcSEcCtD
Mupirocin—Furuncle—Epirubicin—urinary bladder cancer	0.00679	0.00998	CcSEcCtD
Mupirocin—Dermatitis contact—Fluorouracil—urinary bladder cancer	0.00676	0.00994	CcSEcCtD
Mupirocin—Pain—Carboplatin—urinary bladder cancer	0.00674	0.00991	CcSEcCtD
Mupirocin—Abdominal pain—Valrubicin—urinary bladder cancer	0.00673	0.0099	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Doxorubicin—urinary bladder cancer	0.00667	0.00981	CcSEcCtD
Mupirocin—Cellulitis—Etoposide—urinary bladder cancer	0.00653	0.0096	CcSEcCtD
Mupirocin—Furuncle—Doxorubicin—urinary bladder cancer	0.00628	0.00923	CcSEcCtD
Mupirocin—Cough—Mitomycin—urinary bladder cancer	0.00627	0.00922	CcSEcCtD
Mupirocin—Pruritus—Valrubicin—urinary bladder cancer	0.00602	0.00886	CcSEcCtD
Mupirocin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00583	0.00857	CcSEcCtD
Mupirocin—Dizziness—Valrubicin—urinary bladder cancer	0.00563	0.00828	CcSEcCtD
Mupirocin—Swelling—Fluorouracil—urinary bladder cancer	0.00563	0.00827	CcSEcCtD
Mupirocin—Mouth ulceration—Etoposide—urinary bladder cancer	0.00537	0.0079	CcSEcCtD
Mupirocin—Rash—Valrubicin—urinary bladder cancer	0.00537	0.00789	CcSEcCtD
Mupirocin—Dermatitis—Valrubicin—urinary bladder cancer	0.00536	0.00789	CcSEcCtD
Mupirocin—Headache—Valrubicin—urinary bladder cancer	0.00533	0.00784	CcSEcCtD
Mupirocin—Nausea—Valrubicin—urinary bladder cancer	0.00506	0.00744	CcSEcCtD
Mupirocin—Pain—Mitomycin—urinary bladder cancer	0.00502	0.00738	CcSEcCtD
Mupirocin—Swelling—Etoposide—urinary bladder cancer	0.00489	0.00719	CcSEcCtD
Mupirocin—Dry skin—Fluorouracil—urinary bladder cancer	0.00455	0.00669	CcSEcCtD
Mupirocin—Epistaxis—Thiotepa—urinary bladder cancer	0.00436	0.00641	CcSEcCtD
Mupirocin—Haemoglobin—Thiotepa—urinary bladder cancer	0.00417	0.00614	CcSEcCtD
Mupirocin—Haemorrhage—Thiotepa—urinary bladder cancer	0.00415	0.0061	CcSEcCtD
Mupirocin—Stinging—Epirubicin—urinary bladder cancer	0.00411	0.00604	CcSEcCtD
Mupirocin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00401	0.0059	CcSEcCtD
Mupirocin—Dizziness—Mitomycin—urinary bladder cancer	0.00388	0.0057	CcSEcCtD
Mupirocin—Stinging—Doxorubicin—urinary bladder cancer	0.0038	0.00559	CcSEcCtD
Mupirocin—Immune system disorder—Thiotepa—urinary bladder cancer	0.00375	0.00551	CcSEcCtD
Mupirocin—Rash—Mitomycin—urinary bladder cancer	0.0037	0.00544	CcSEcCtD
Mupirocin—Dermatitis—Mitomycin—urinary bladder cancer	0.0037	0.00543	CcSEcCtD
Mupirocin—Headache—Mitomycin—urinary bladder cancer	0.00368	0.0054	CcSEcCtD
Mupirocin—Cellulitis—Epirubicin—urinary bladder cancer	0.00366	0.00538	CcSEcCtD
Mupirocin—Erythema—Thiotepa—urinary bladder cancer	0.00361	0.00531	CcSEcCtD
Mupirocin—Epistaxis—Fluorouracil—urinary bladder cancer	0.00361	0.00531	CcSEcCtD
Mupirocin—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00351	0.00516	CcSEcCtD
Mupirocin—Rhinitis—Gemcitabine—urinary bladder cancer	0.0035	0.00515	CcSEcCtD
Mupirocin—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00349	0.00514	CcSEcCtD
Mupirocin—Nausea—Mitomycin—urinary bladder cancer	0.00348	0.00512	CcSEcCtD
Mupirocin—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00347	0.0051	CcSEcCtD
Mupirocin—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00345	0.00507	CcSEcCtD
Mupirocin—Rhinitis—Fluorouracil—urinary bladder cancer	0.00344	0.00506	CcSEcCtD
Mupirocin—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00343	0.00505	CcSEcCtD
Mupirocin—Pharyngitis—Fluorouracil—urinary bladder cancer	0.00341	0.00501	CcSEcCtD
Mupirocin—Cellulitis—Doxorubicin—urinary bladder cancer	0.00339	0.00498	CcSEcCtD
Mupirocin—Dermatitis contact—Epirubicin—urinary bladder cancer	0.00329	0.00484	CcSEcCtD
Mupirocin—Mouth ulceration—Methotrexate—urinary bladder cancer	0.00322	0.00473	CcSEcCtD
Mupirocin—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00316	0.00464	CcSEcCtD
Mupirocin—Cough—Thiotepa—urinary bladder cancer	0.00315	0.00464	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00306	0.00449	CcSEcCtD
Mupirocin—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.00304	0.00448	CcSEcCtD
Mupirocin—Erythema—Gemcitabine—urinary bladder cancer	0.00304	0.00447	CcSEcCtD
Mupirocin—Mouth ulceration—Epirubicin—urinary bladder cancer	0.00301	0.00443	CcSEcCtD
Mupirocin—Erythema—Fluorouracil—urinary bladder cancer	0.00299	0.0044	CcSEcCtD
Mupirocin—Immune system disorder—Cisplatin—urinary bladder cancer	0.00294	0.00432	CcSEcCtD
Mupirocin—Skin disorder—Thiotepa—urinary bladder cancer	0.00287	0.00421	CcSEcCtD
Mupirocin—Erythema—Cisplatin—urinary bladder cancer	0.00283	0.00417	CcSEcCtD
Mupirocin—Mouth ulceration—Doxorubicin—urinary bladder cancer	0.00279	0.00409	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00274	0.00402	CcSEcCtD
Mupirocin—Immune system disorder—Etoposide—urinary bladder cancer	0.00269	0.00396	CcSEcCtD
Mupirocin—Eczema—Epirubicin—urinary bladder cancer	0.00269	0.00395	CcSEcCtD
Mupirocin—Cough—Gemcitabine—urinary bladder cancer	0.00265	0.0039	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00257	0.00378	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00256	0.00377	CcSEcCtD
Mupirocin—Dysgeusia—Etoposide—urinary bladder cancer	0.00254	0.00374	CcSEcCtD
Mupirocin—Pain—Thiotepa—urinary bladder cancer	0.00252	0.00371	CcSEcCtD
Mupirocin—Eczema—Doxorubicin—urinary bladder cancer	0.00249	0.00366	CcSEcCtD
Mupirocin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00248	0.00365	CcSEcCtD
Mupirocin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00244	0.00359	CcSEcCtD
Mupirocin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00241	0.00355	CcSEcCtD
Mupirocin—Skin disorder—Gemcitabine—urinary bladder cancer	0.00241	0.00354	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.0024	0.00352	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00237	0.00348	CcSEcCtD
Mupirocin—Urticaria—Thiotepa—urinary bladder cancer	0.00234	0.00345	CcSEcCtD
Mupirocin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00233	0.00343	CcSEcCtD
Mupirocin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00231	0.0034	CcSEcCtD
Mupirocin—Cough—Etoposide—urinary bladder cancer	0.00227	0.00333	CcSEcCtD
Mupirocin—Skin disorder—Cisplatin—urinary bladder cancer	0.00225	0.0033	CcSEcCtD
Mupirocin—Dry skin—Epirubicin—urinary bladder cancer	0.00222	0.00326	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.0022	0.00323	CcSEcCtD
Mupirocin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00217	0.0032	CcSEcCtD
Mupirocin—Pain—Gemcitabine—urinary bladder cancer	0.00212	0.00312	CcSEcCtD
Mupirocin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00212	0.00312	CcSEcCtD
Mupirocin—Pruritus—Thiotepa—urinary bladder cancer	0.00209	0.00307	CcSEcCtD
Mupirocin—Pain—Fluorouracil—urinary bladder cancer	0.00209	0.00307	CcSEcCtD
Mupirocin—Skin disorder—Etoposide—urinary bladder cancer	0.00206	0.00303	CcSEcCtD
Mupirocin—Dry skin—Doxorubicin—urinary bladder cancer	0.00205	0.00301	CcSEcCtD
Mupirocin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00202	0.00297	CcSEcCtD
Mupirocin—Pain—Cisplatin—urinary bladder cancer	0.00198	0.00291	CcSEcCtD
Mupirocin—Dizziness—Thiotepa—urinary bladder cancer	0.00195	0.00287	CcSEcCtD
Mupirocin—Urticaria—Fluorouracil—urinary bladder cancer	0.00194	0.00285	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—urinary bladder cancer	0.00188	0.00276	CcSEcCtD
Mupirocin—Rash—Thiotepa—urinary bladder cancer	0.00186	0.00273	CcSEcCtD
Mupirocin—Dermatitis—Thiotepa—urinary bladder cancer	0.00186	0.00273	CcSEcCtD
Mupirocin—Headache—Thiotepa—urinary bladder cancer	0.00185	0.00272	CcSEcCtD
Mupirocin—Pain—Etoposide—urinary bladder cancer	0.00181	0.00266	CcSEcCtD
Mupirocin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0018	0.00264	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—urinary bladder cancer	0.0018	0.00264	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—urinary bladder cancer	0.00179	0.00263	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—urinary bladder cancer	0.00177	0.00261	CcSEcCtD
Mupirocin—Epistaxis—Epirubicin—urinary bladder cancer	0.00176	0.00258	CcSEcCtD
Mupirocin—Pruritus—Gemcitabine—urinary bladder cancer	0.00176	0.00258	CcSEcCtD
Mupirocin—Nausea—Thiotepa—urinary bladder cancer	0.00175	0.00258	CcSEcCtD
Mupirocin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00173	0.00255	CcSEcCtD
Mupirocin—Pruritus—Fluorouracil—urinary bladder cancer	0.00173	0.00254	CcSEcCtD
Mupirocin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0017	0.00251	CcSEcCtD
Mupirocin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0017	0.0025	CcSEcCtD
Mupirocin—Urticaria—Etoposide—urinary bladder cancer	0.00168	0.00248	CcSEcCtD
Mupirocin—Haemoglobin—Epirubicin—urinary bladder cancer	0.00168	0.00247	CcSEcCtD
Mupirocin—Rhinitis—Epirubicin—urinary bladder cancer	0.00168	0.00246	CcSEcCtD
Mupirocin—Abdominal pain—Etoposide—urinary bladder cancer	0.00168	0.00246	CcSEcCtD
Mupirocin—Haemorrhage—Epirubicin—urinary bladder cancer	0.00167	0.00246	CcSEcCtD
Mupirocin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00167	0.00245	CcSEcCtD
Mupirocin—Pharyngitis—Epirubicin—urinary bladder cancer	0.00166	0.00244	CcSEcCtD
Mupirocin—Epistaxis—Doxorubicin—urinary bladder cancer	0.00163	0.00239	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—urinary bladder cancer	0.00161	0.00237	CcSEcCtD
Mupirocin—Dizziness—Fluorouracil—urinary bladder cancer	0.00161	0.00237	CcSEcCtD
Mupirocin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00158	0.00233	CcSEcCtD
Mupirocin—Rash—Gemcitabine—urinary bladder cancer	0.00156	0.0023	CcSEcCtD
Mupirocin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00156	0.0023	CcSEcCtD
Mupirocin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00156	0.0023	CcSEcCtD
Mupirocin—Erythema—Methotrexate—urinary bladder cancer	0.00156	0.00229	CcSEcCtD
Mupirocin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00155	0.00229	CcSEcCtD
Mupirocin—Headache—Gemcitabine—urinary bladder cancer	0.00155	0.00229	CcSEcCtD
Mupirocin—Rhinitis—Doxorubicin—urinary bladder cancer	0.00155	0.00228	CcSEcCtD
Mupirocin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00155	0.00227	CcSEcCtD
Mupirocin—Rash—Fluorouracil—urinary bladder cancer	0.00154	0.00226	CcSEcCtD
Mupirocin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00154	0.00226	CcSEcCtD
Mupirocin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00154	0.00226	CcSEcCtD
Mupirocin—Headache—Fluorouracil—urinary bladder cancer	0.00153	0.00225	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—urinary bladder cancer	0.00152	0.00224	CcSEcCtD
Mupirocin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00151	0.00222	CcSEcCtD
Mupirocin—Pruritus—Etoposide—urinary bladder cancer	0.0015	0.0022	CcSEcCtD
Mupirocin—Nausea—Gemcitabine—urinary bladder cancer	0.00147	0.00217	CcSEcCtD
Mupirocin—Rash—Cisplatin—urinary bladder cancer	0.00146	0.00214	CcSEcCtD
Mupirocin—Dermatitis—Cisplatin—urinary bladder cancer	0.00146	0.00214	CcSEcCtD
Mupirocin—Erythema—Epirubicin—urinary bladder cancer	0.00146	0.00214	CcSEcCtD
Mupirocin—Diarrhoea—Etoposide—urinary bladder cancer	0.00145	0.00213	CcSEcCtD
Mupirocin—Nausea—Fluorouracil—urinary bladder cancer	0.00145	0.00213	CcSEcCtD
Mupirocin—Dysgeusia—Epirubicin—urinary bladder cancer	0.00143	0.0021	CcSEcCtD
Mupirocin—Dizziness—Etoposide—urinary bladder cancer	0.0014	0.00206	CcSEcCtD
Mupirocin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.0014	0.00205	CcSEcCtD
Mupirocin—Nausea—Cisplatin—urinary bladder cancer	0.00137	0.00202	CcSEcCtD
Mupirocin—Cough—Methotrexate—urinary bladder cancer	0.00136	0.002	CcSEcCtD
Mupirocin—Erythema—Doxorubicin—urinary bladder cancer	0.00135	0.00198	CcSEcCtD
Mupirocin—Rash—Etoposide—urinary bladder cancer	0.00134	0.00196	CcSEcCtD
Mupirocin—Dermatitis—Etoposide—urinary bladder cancer	0.00133	0.00196	CcSEcCtD
Mupirocin—Headache—Etoposide—urinary bladder cancer	0.00133	0.00195	CcSEcCtD
Mupirocin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00132	0.00194	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00132	0.00193	CcSEcCtD
Mupirocin—Cough—Epirubicin—urinary bladder cancer	0.00127	0.00187	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00127	0.00187	CcSEcCtD
Mupirocin—Nausea—Etoposide—urinary bladder cancer	0.00126	0.00185	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—urinary bladder cancer	0.00123	0.00181	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00123	0.00181	CcSEcCtD
Mupirocin—Dry mouth—Epirubicin—urinary bladder cancer	0.00121	0.00178	CcSEcCtD
Mupirocin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00119	0.00175	CcSEcCtD
Mupirocin—Cough—Doxorubicin—urinary bladder cancer	0.00118	0.00173	CcSEcCtD
Mupirocin—Skin disorder—Epirubicin—urinary bladder cancer	0.00115	0.0017	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00114	0.00167	CcSEcCtD
Mupirocin—Dry mouth—Doxorubicin—urinary bladder cancer	0.00112	0.00165	CcSEcCtD
Mupirocin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.0011	0.00162	CcSEcCtD
Mupirocin—Pain—Methotrexate—urinary bladder cancer	0.00109	0.0016	CcSEcCtD
Mupirocin—Skin disorder—Doxorubicin—urinary bladder cancer	0.00107	0.00157	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00104	0.00153	CcSEcCtD
Mupirocin—Pain—Epirubicin—urinary bladder cancer	0.00102	0.00149	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—urinary bladder cancer	0.00101	0.00148	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—urinary bladder cancer	0.001	0.00148	CcSEcCtD
Mupirocin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000971	0.00143	CcSEcCtD
Mupirocin—Urticaria—Epirubicin—urinary bladder cancer	0.000944	0.00139	CcSEcCtD
Mupirocin—Pain—Doxorubicin—urinary bladder cancer	0.00094	0.00138	CcSEcCtD
Mupirocin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000939	0.00138	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000935	0.00137	CcSEcCtD
Mupirocin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000899	0.00132	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—urinary bladder cancer	0.000898	0.00132	CcSEcCtD
Mupirocin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000875	0.00129	CcSEcCtD
Mupirocin—Urticaria—Doxorubicin—urinary bladder cancer	0.000873	0.00128	CcSEcCtD
Mupirocin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000869	0.00128	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000869	0.00128	CcSEcCtD
Mupirocin—Pruritus—Epirubicin—urinary bladder cancer	0.00084	0.00124	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—urinary bladder cancer	0.000839	0.00123	CcSEcCtD
Mupirocin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000813	0.00119	CcSEcCtD
Mupirocin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00081	0.00119	CcSEcCtD
Mupirocin—Rash—Methotrexate—urinary bladder cancer	0.0008	0.00118	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—urinary bladder cancer	0.0008	0.00118	CcSEcCtD
Mupirocin—Headache—Methotrexate—urinary bladder cancer	0.000795	0.00117	CcSEcCtD
Mupirocin—Dizziness—Epirubicin—urinary bladder cancer	0.000786	0.00115	CcSEcCtD
Mupirocin—Pruritus—Doxorubicin—urinary bladder cancer	0.000778	0.00114	CcSEcCtD
Mupirocin—Nausea—Methotrexate—urinary bladder cancer	0.000754	0.00111	CcSEcCtD
Mupirocin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000752	0.00111	CcSEcCtD
Mupirocin—Rash—Epirubicin—urinary bladder cancer	0.000749	0.0011	CcSEcCtD
Mupirocin—Dermatitis—Epirubicin—urinary bladder cancer	0.000748	0.0011	CcSEcCtD
Mupirocin—Headache—Epirubicin—urinary bladder cancer	0.000744	0.00109	CcSEcCtD
Mupirocin—Dizziness—Doxorubicin—urinary bladder cancer	0.000727	0.00107	CcSEcCtD
Mupirocin—Nausea—Epirubicin—urinary bladder cancer	0.000706	0.00104	CcSEcCtD
Mupirocin—Rash—Doxorubicin—urinary bladder cancer	0.000693	0.00102	CcSEcCtD
Mupirocin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000692	0.00102	CcSEcCtD
Mupirocin—Headache—Doxorubicin—urinary bladder cancer	0.000689	0.00101	CcSEcCtD
Mupirocin—Nausea—Doxorubicin—urinary bladder cancer	0.000653	0.00096	CcSEcCtD
